Clinical Trials Directory

Trials / Terminated

TerminatedNCT00765544

Targeted Lower Extremity Joint Training

Robot-assisted Ankle Rehabilitation for Multiple Sclerosis (Anklebot)

Status
Terminated
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
10 (actual)
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The presence of foot drop limits normal gait. Our prior data has suggested that approximately 30% of MS patients have foot drop. Although we have observed that "task-specific" rehabilitation using the Lokomat can improve ambulation in chronic MS patients, subjects with "foot drop" have difficulty translating task-specific training to normative gait patterns over ground, despite improving speed and endurance. One of the key limitations of the Lokomat is a lack of robot-assisted training for the ankle joint. The Anklebot, an MIT-developed rehabilitation robot for the ankle, has the potential to address this. The device can move throughout three planes and train ankle flexion, extension, inversion and eversion; however, therapy with the Anklebot alone does not train the knee or hip. We plan to test whether subject foot drop and overall gait benefit more from Anklebot therapy alone or a combination of Anklebot and Lokomat.

Conditions

Interventions

TypeNameDescription
DEVICEAnklebotThe Ankle-Bot (Wheeler et al., 2004) is a stand-alone robot assisted device that is worn via a leather boot and knee brace (Fig.1). The Ankle-Bot can assist ankle movement throughout 3 planes. The percentage of force generated by the Ankle-Bot can be adjusted from no help, 0% assistance to 100% assistance. The device is low impedance and a subject can easily over come the forces generated by the Ankle-Bot. The Ankle-Bot will guide and assist the subject into ankle flexion, extension, inversion and eversion.
DEVICELokomatThe Lokomat is a motor driven exoskeleton device that employs a body weight support suspension system and treadmill .

Timeline

Start date
2008-09-01
Primary completion
2008-09-01
Completion
2008-09-01
First posted
2008-10-03
Last updated
2013-09-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00765544. Inclusion in this directory is not an endorsement.